National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Understanding Cancer Series: Genetic Variation (SNPs)
< Back to Main
    Posted: 01/28/2005    Reviewed: 09/01/2006
Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
View/Print PDF  View/Print PDF
View/Print PowerPoint  View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Office of Biorepositories and Biospecimen Research

The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates
Slide 38 : SNPs Profiles and Response to Drug Therapy previousnext

Doctors hope that by studying SNP profiles in populations, correlations will emerge between certain SNP profiles and specific responses to cancer treatment.

In the earlier example of two breast cancer patients, one did respond to the specific drug treatment, and the other did not. It may soon be possible to show that an entire group of patients responding well to breast cancer treatment repeatedly display profiles within a recurring set (e.g., A and E), while a group of non-responders repeatedly display profiles outside the set. In the future, after a doctor has diagnosed breast cancer in a new patient, he may also request a SNP profile and use the information to help advise his patient about her treatment options.

SNPs Profiles and Response to Drug Therapy

< Previous  |  Index  |  Next Slide >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov